Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

FEATURE-British children in limbo over gender therapy after court ruling

Mon, 15th Feb 2021 17:05

By Rachel Savage

LONDON, Feb 15 (Thomson Reuters Foundation) - Almost as soon
as she could speak, Nina told her parents she was not a boy and
she has lived as a girl since she was seven. Until recently, she
was happy.

But now aged 12 and wanting to stop the onset of male
puberty, a ruling by Britain's High Court has plunged Nina and
dozens of other children struggling with gender dysphoria into
limbo by restricting access to puberty-blocking drugs.

The judges ruled that under-16s were unlikely to be able to
give informed consent to such medication, and doctors must now
get a judge's approval - a so-called "best interests order" - to
prescribe them to adolescent patients.

Days after the ruling, Nina's appointment the following week
with specialists - whom she hoped would prescribe the medication
- was cancelled and no new date was scheduled.

With the court ruling leaving a void in treatment, some
parents are now filling the gap left by seeking drugs for their
children from privately funded services.

"I feel like I'm living in a nightmare," said Nina's mother,
Juliet, whose daughter has attended England's sole youth gender
clinic - the Gender Identity Development Service (GIDS) - since
she was five.

"If in your head you are female but your body starts to
develop as a male in your teenage years, it just must be the
most horrendous thing," said Juliet, whose name - along with
those of all parents and children in this article - has been
changed to protect their identities.

The ruling came as rising numbers of adolescents globally
seek to change gender, dividing those who fear doctors are too
hasty in prescribing puberty blockers and cross-sex hormones and
those worried about access to medication they deem life-saving.

Puberty blockers, which are used to prevent the onset of
sexual maturity, have become the focus of a fierce global debate
about the age at which a child can decide to transition gender.

In Britain the number of children referred to GIDS has risen
nearly 30-fold in the past decade and waiting lists are more
than 18 months long.

About 2,660 under-18s were referred to GIDS in the year to
March 2020, while 161 were referred on by GIDS to specialist
endocrinologists who prescribe puberty blockers, according to
the clinic's data.

The World Professional Association for Transgender Health, a
U.S.-based body of doctors specialised in treating trans people,
said puberty blocking drugs can be used to help alleviate gender
dysphoria and give children time to consider future options.

The medication can stop irreversible physical changes for
patients, such as their voice breaking, WPATH's guidelines
state.

But the drugs' use is controversial. There is little
research about the long-term effects and critics say they are
prescribed too freely - putting sometimes-vulnerable children on
a course to more permanent transition treatments.

Keira Bell, who took puberty blockers aged 16, testosterone
at 17 and had a double mastectomy at 20, brought the court case
that resulted in puberty blockers being restricted after coming
to regret the medical treatment she had to transition.

Bell, now 23, told reporters after the Dec. 1 judgment that
she was delighted by the outcome and wished it had been made
before she "embarked on the devastating experiment of puberty
blockers".

'ABSOLUTELY DEVASTATED'

Tom, a 12-year-old patient of the London-based youth gender
clinic run by the Tavistock and Portman NHS Foundation Trust,
had been waiting for an appointment with an endocrinologist when
the High Court issued its ruling, said his mother, Naomi.

"When the (court) outcome came, he was just absolutely
devastated," she said. "Straight away he just went completely
down. And since then he's stopped eating."

Some former staff and parents of children with dysphoria,
however, have welcomed tighter restrictions on the use of
puberty blockers at GIDS, voicing concern about whether children
as young as 10 can be sure about their gender identity.

"No child can be born in the wrong body," said David Bell,
a retired adult psychiatrist and a former staff representative
on the Tavistock and Portman NHS Foundation Trust's Council of
Governors.

While he said he had not worked with trans children
specifically, Bell said he was contacted in 2018 by 10 former
and then-current GIDS clinicians who were concerned puberty
blockers were being prescribed too easily.

But another GIDS clinician, who spoke anonymously because of
not being authorised to speak publicly, disputed the assessment
of the medical professionals who raised concerns with Bell.

"The idea that people are being rushed into decisions is
simply not true," the clinician said. "As a service we are
actually very conservative in the way we approach gender
identity."

'TIME TO THINK'

Like Nina, Tom's mother Naomi said he had been "adamant"
about being a boy since he started to talk, but COVID-19 had
delayed his assessments for medication even before the court
ruling.

"I'm just pinning all of my hopes on the best interests
(court) order," said Naomi, referring to the new requirement for
patients aged under 16 to secure a judge's approval to access
the medication.

Parents such as Naomi told the Thomson Reuters Foundation
they had received little guidance so far on how to seek a court
order, and so far none have been issued.

A Tavistock and Portman NHS Foundation Trust spokeswoman
said patients such as Nina and Tom, who were referred to
endocrinologists before Dec. 1 but had not started taking the
drugs, would soon be advised on applying for the court orders.

The trust is appealing against the High Court ruling, which
prompted England's National Health Service (NHS) to tighten its
rules on accessing the drugs.

The High Court "set out a clear need for an additional layer
of safeguarding for children which is why the Tavistock and
Portman NHS Foundation Trust themselves decided not to make new
referrals", an NHS spokeswoman said by email.

Caroline's daughter Lily starting living as a girl at the
age of six, having said she was a girl from the age of three.

Lily was due to have an endocrinology appointment when she
turns 12 in March, but now that is in doubt Caroline has paid a
private gender care service to secure puberty blockers for her
daughter.

She said she would continue to skirt NHS channels to secure
supplies of the drug while the uncertainty triggered by the
court ruling continued.

"She knows her body, she's not stupid," Caroline said. "It's
giving her time to think about it, to discover herself and think
about it. We're not opposed to her going back to being a boy.
She can do what she likes."
(Reporting by Rachel Savage @rachelmsavage; Editing by Belinda
Goldsmith
Please credit the Thomson Reuters Foundation, the charitable arm
of Thomson Reuters, that covers the lives of people around the
world who struggle to live freely or fairly. Visit http://news.trust.org)

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.